Source: Current Vascular Pharmacology. Unidade: FM
Subjects: DOENÇAS GENÉTICAS, MUTAÇÃO GENÉTICA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AL-ASHWAL, Abdullah et al. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, v. 13, n. 6, p. 759-770, 2015Tradução . . Disponível em: https://doi.org/10.2174/1570161113666150827125040. Acesso em: 17 nov. 2024.APA
Al-Ashwal, A., Alnouri, F., Sabbour, H., Al-Mahfouz, A., Al-Sayed, N., Razzaghy-Azar, M., et al. (2015). Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel. Current Vascular Pharmacology, 13( 6), 759-770. doi:10.2174/1570161113666150827125040NLM
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2174/1570161113666150827125040Vancouver
Al-Ashwal A, Alnouri F, Sabbour H, Al-Mahfouz A, Al-Sayed N, Razzaghy-Azar M, Al-Allaf F, Al-Waili K, Banerjee Y, Genest J, Santos RD, Al-Rasadi K. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel [Internet]. Current Vascular Pharmacology. 2015 ; 13( 6): 759-770.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2174/1570161113666150827125040
